172 related articles for article (PubMed ID: 17850776)
21. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
22. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia induces apoptosis of HUVECs in an in vitro capillary model by activating proapoptotic signal p38 through suppression of ERK1/2.
Eguchi R; Suzuki A; Miyakaze S; Kaji K; Ohta T
Cell Signal; 2007 Jun; 19(6):1121-31. PubMed ID: 17303382
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Wang Q; Zhou Y; Wang X; Evers BM
Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
[TBL] [Abstract][Full Text] [Related]
25. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.
Tapinos N; Rambukkana A
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9188-93. PubMed ID: 15967991
[TBL] [Abstract][Full Text] [Related]
26. Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling.
Xia S; Menden HL; Korfhagen TR; Kume T; Sampath V
J Physiol; 2018 Apr; 596(8):1397-1417. PubMed ID: 29380370
[TBL] [Abstract][Full Text] [Related]
27. Cell-based assays to probe the ERK MAP kinase pathway in endothelial cells.
Wyler MR; Smith DH; Cayanis E; Többen U; Aulner N; Mayer T
Methods Mol Biol; 2009; 486():29-41. PubMed ID: 19347614
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the ERK phosphorylation plays a role in terbinafine-induced p21 up-regulation and DNA synthesis inhibition in human vascular endothelial cells.
Ho PY; Hsu SP; Liang YC; Kuo ML; Ho YS; Lee WS
Toxicol Appl Pharmacol; 2008 May; 229(1):86-93. PubMed ID: 18272192
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
30. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
31. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
32. Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9.
Park H; Drevelle O; Daviau A; Senta H; Bergeron E; Faucheux N
Anticancer Drugs; 2013 Mar; 24(3):278-90. PubMed ID: 23262982
[TBL] [Abstract][Full Text] [Related]
33. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
[TBL] [Abstract][Full Text] [Related]
34. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.
Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH
Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907
[TBL] [Abstract][Full Text] [Related]
35. Involvement of c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2 in EGF-induced angiogenesis.
Shen K; Sheng Y; Ji L; Wang Z
Cell Biol Int; 2010 Dec; 34(12):1213-8. PubMed ID: 20735357
[TBL] [Abstract][Full Text] [Related]
36. The influence of enamel matrix derivative on the angiogenic activity of primary endothelial cells.
Kasaj A; Meister J; Lehmann K; Stratul SI; Schlee M; Stein JM; Willershausen B; Schmidt M
J Periodontal Res; 2012 Aug; 47(4):479-87. PubMed ID: 22212171
[TBL] [Abstract][Full Text] [Related]
37. Magnesium deprivation inhibits a MEK-ERK cascade and cell proliferation in renal epithelial Madin-Darby canine kidney cells.
Ikari A; Atomi K; Kinjo K; Sasaki Y; Sugatani J
Life Sci; 2010 May; 86(19-20):766-73. PubMed ID: 20338184
[TBL] [Abstract][Full Text] [Related]
38. Ca2+ influx through reverse mode Na+/Ca2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells.
Andrikopoulos P; Baba A; Matsuda T; Djamgoz MBA; Yaqoob MM; Eccles SA
J Biol Chem; 2011 Nov; 286(44):37919-37931. PubMed ID: 21873429
[TBL] [Abstract][Full Text] [Related]
39. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
40. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
